ArticleCancers2026

A Five-Biomarker IHC-Based Signature Predicting Outcome in Breast Cancer Patients Following Adjuvant Anthracycline-Based Chemotherapy.

Siyao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.